Tejal Somvanshi
A new federal report has confirmed what infectious disease doctors have warned for years: drug-resistant bacteria and fungi have spread beyond hospital walls and are now killing tens of thousands of Americans annually. The CDC released its updated Antimicrobial Resistance Threats Report on Tuesday, estimating that 19 tracked drug-resistant germs collectively cause 9.7 million infections and roughly 50,800 deaths in the United States every year.
The report—based on 2023 data and released October 27, 2026—classifies the 19 threats into urgent, serious, and concerning categories. The Watch List tracks additional emerging pathogens separately.
Two pathogens drove the steepest surges. NDM-CRE—a class of carbapenem-resistant gut bacteria that can resist nearly all antibiotics—increased by 461 percent between 2019 and 2023. The multidrug-resistant fungus *Candida auris* grew nearly fivefold in clinical cases between 2019 and 2022, with some strains documented as pan-resistant to antifungal drugs, though pan-resistance remains rare rather than typical. The CDC noted that the overall death toll rose from its previous 2019 estimate of 35,000 partly because surveillance methods changed—making direct numerical comparisons between the two reports unreliable, even as specific pathogen increases like NDM-CRE represent a verifiable real-world surge.
Drug-resistant infections are no longer confined to hospital intensive care units—they now threaten everyday households and college campuses. Drug-resistant meningococcus is spreading through respiratory and throat secretions during close or prolonged contact, including in dormitory settings. Drug-resistant ringworm has been flagged on the CDC’s Watch List, with misuse of over-the-counter combination steroid-antifungal creams identified as a contributing factor. Patients should avoid using leftover antibiotics or combination steroid-antifungal creams without a proper diagnosis, and families should ensure college-age adults are current on meningococcal vaccines.
Hospital Superbugs Surge: NDM-CRE Up 461% and Candida Auris Nearly Fivefold
NDM-CRE bacteria produce an enzyme called New Delhi metallo-beta-lactamase that dismantles carbapenem antibiotics—considered a last resort for severe infections. *Candida auris* is a yeast that persists on hospital surfaces and equipment and can be difficult to eliminate with standard disinfection protocols. It can cause fatal bloodstream infections in immunocompromised patients.
Drug-resistant *Neisseria meningitidis*—the bacteria behind bacterial meningitis—is now classified as a “serious threat” by the CDC, with spread linked to close or prolonged respiratory contact in shared settings. The CDC also added drug-resistant ringworm to its Watch List, noting that misuse of combination steroid-antifungal creams can suppress local immune response and allow resistant fungal strains to develop.
From College Dorms to Skin Creams: Superbugs Enter Everyday Life
The report renewed calls to pass the bipartisan PASTEUR Act, which would create a subscription-style federal funding model for new antibiotic development. The gap in pharmaceutical investment in new antibiotics is cited in the report as a factor allowing resistant pathogens to outpace available treatments.
For years, most Americans viewed superbugs strictly as a hazard for elderly patients in hospital ICUs. The CDC’s newly added threats show resistance has moved into spaces most people would never think to check: the dorm bathroom, the medicine cabinet, the tube of OTC antifungal cream bought at a drugstore.
FAQ
Which drug-resistant superbugs are surging the fastest in the new CDC report? NDM-CRE infections surged 461 percent between 2019 and 2023, while *Candida auris* fungal infections grew nearly fivefold in clinical cases from 2019 to 2022. The CDC also newly classified drug-resistant meningococcus as a serious threat and placed drug-resistant ringworm on its Watch List.
How many Americans die from antibiotic-resistant infections each year? The CDC’s 2026 report estimates roughly 50,800 Americans die annually from drug-resistant infections caused by 19 tracked pathogens, generating an estimated 9.7 million infections total. Note that the previous 2019 estimate was 35,000; the CDC explicitly states that changes in data sources and surveillance methods mean these two totals cannot be directly compared.
What is NDM-CRE and why did it increase by 461 percent? NDM-CRE are bacteria that produce an enzyme disabling carbapenem antibiotics—among the strongest drugs available for severe infections. Cases rose 461 percent between 2019 and 2023. The CDC did not assign a single cause; contributing factors include international transmission of resistance genes, healthcare facility spread, and broader antimicrobial overuse.
The CDC’s full Antimicrobial Resistance Threats Report is available at cdc.gov. Congress is currently weighing the PASTEUR Act as one mechanism to revive antibiotic development funding. More on CDC infectious disease and superbug warnings and hospital infection control standards at cruxbuzz.com.
